49 results on '"Beyer, K."'
Search Results
2. Peanut���induced anaphylaxis in children and adolescents: Data from the European Anaphylaxis Registry
- Author
-
Maris, Ioana, D��lle���Bierke, Sabine, Renaudin, Jean���Marie, Lange, Lars, Koehli, Alice, Spindler, Thomas, Hourihane, Jonathan, Scherer, Kathrin, Nemat, Katja, Kemen, C., Neust��dter, Irena, Vogelberg, Christian, Reese, Thomas, Yildiz, Ismail, Szepfalusi, Zsolt, Ott, Hagen, Straube, Helen, Papadopoulos, Nikolaos G., H��mmerling, Susanne, Staden, Ute, Polz, Michael, Mustakov, Tihomir, Cichocka���Jarosz, Ewa, Cocco, Renata, Fiocchi, Alessandro Giovanni, Fernandez���Rivas, Montserrat, Worm, Margitta, Gr��nhagen, J, Wittenberg, M, Beyer, K, Henschel, A, K��per, S, M��ser, A, Fuchs, T, Ru��ff, F, Wedi, B, Hansen, G, Buck, T, B��sselberg, J, Dr��gerdt, R, Pfeffer, L, Dickel, H, K��rner���Rettberg, C, Merk, H, Lehmann, S, Bauer, A, Nordwig, A, Zeil, S, Hannapp, C, Wagner, N, Rietschel, E, Hunzelmann, N, Huseynow, I, Treudler, R, Aurich, S, Prenzel, F, Klimek, L, Pfaar, O, Reider, N, Aberer, W, Varga, E, Bogatu, B, Schmid���Grendelmeier, P, Guggenheim, R, Riffelmann, F, Kreft, B, Kinaciyan, K, Hartl, L, Ebner, C, Horak, F, Brehler, R, Witte, J, Buss, M, Hompes, S, Bieber, T, Gernert, S, B��cheler, M, Rabe, U, Brosi, W, Nestoris, S, Hawranek, T, Lang, R, Bruns, R, Pf��hler, C, Eng, P, Schweitzer���Krantz, S, Meller, S, Rebmann, H, Fischer, J, Stichtenoth, G, Thies, S, Gerstlauer, M, Utz, P, Neust��dter, I, Klinge, J, Volkmuth, S, Plank���Habibi, S, Schilling, B, Kleinheinz, A, Br��ckner, A, Sch��kel, K, Manolaraki, I, Kowalski, M, Solarewicz���Madajek, K, Tscheiller, S, Seidenberg, J, Cardona, V, Garcia, B, Bilo, M, Caba��es Higuero, N, Vega Castro, A, Poziomkowska���G��sicka, I, B��sing, S, Virchow, C, Christoff, G, Jappe, U, M��ller, S, Kn��pfel, F, Correard, A���K, Rogala, B, Montoro, A, Brandes, A, Muraro, A, Zimmermann, N, Hernandez, D, Minale, P, Niederwimmer, J, Zahel, B, Dahdah, L, Arasi, S, Reissig, A, Eitelberger, F, Asero, R, Hermann, F, Zeidler, S, Pistauer, S, Gei��ler, M, Ensina, L, Plaza Martin, A, Meister, J, Stieglitz, S, Hamelmann, E, and Network For Online Registration Of Anaphylaxis (NORA)
- Subjects
0301 basic medicine ,Allergy ,medicine.medical_specialty ,Adolescent ,Arachis ,Epinephrine ,Immunology ,Peanut allergy ,Peanut-induced anaphylaxis ,paediatrics ,03 medical and health sciences ,0302 clinical medicine ,Food allergy ,Internal medicine ,medicine ,anaphylaxis ,Humans ,Immunology and Allergy ,Peanut Hypersensitivity ,In patient ,Registries ,Child ,Asthma ,food allergy ,business.industry ,food and beverages ,medicine.disease ,Comorbidity ,030104 developmental biology ,030228 respiratory system ,business ,Anaphylaxis ,600 Technik, Medizin, angewandte Wissenschaften::610 Medizin und Gesundheit::610 Medizin und Gesundheit - Abstract
Background Peanut allergy has a rising prevalence in high-income countries, affecting 0.5%-1.4% of children. This study aimed to better understand peanut anaphylaxis in comparison to anaphylaxis to other food triggers in European children and adolescents. Methods Data was sourced from the European Anaphylaxis Registry via an online questionnaire, after in-depth review of food-induced anaphylaxis cases in a tertiary paediatric allergy centre. Results 3514 cases of food anaphylaxis were reported between July 2007 - March 2018, 56% in patients younger than 18 years. Peanut anaphylaxis was recorded in 459 children and adolescents (85% of all peanut anaphylaxis cases). Previous reactions (42% vs. 38%; p = .001), asthma comorbidity (47% vs. 35%; p < .001), relevant cofactors (29% vs. 22%; p = .004) and biphasic reactions (10% vs. 4%; p = .001) were more commonly reported in peanut anaphylaxis. Most cases were labelled as severe anaphylaxis (Ring&Messmer grade III 65% vs. 56% and grade IV 1.1% vs. 0.9%; p = .001). Self-administration of intramuscular adrenaline was low (17% vs. 15%), professional adrenaline administration was higher in non-peanut food anaphylaxis (34% vs. 26%; p = .003). Hospitalization was higher for peanut anaphylaxis (67% vs. 54%; p = .004). Conclusions The European Anaphylaxis Registry data confirmed peanut as one of the major causes of severe, potentially life-threatening allergic reactions in European children, with some characteristic features e.g., presence of asthma comorbidity and increased rate of biphasic reactions. Usage of intramuscular adrenaline as first-line treatment is low and needs to be improved. The Registry, designed as the largest database on anaphylaxis, allows continuous assessment of this condition.
- Published
- 2021
- Full Text
- View/download PDF
3. Spezifische orale Toleranzinduktion bei Nahrungsmittelallergie
- Author
-
Staden, U., Rolinck-Werninghaus, C., Beyer, K., and Niggemann, B.
- Published
- 2006
- Full Text
- View/download PDF
4. Allergen immunotherapy for IgE-mediated food allergy : a systematic review and meta-analysis
- Author
-
Nurmatov, U., Dhami, S., Arasi, S., Pajno, G. B., Fernandez-Rivas, M., Muraro, A., Roberts, G., Akdis, C., Alvaro-Lozano, M., Beyer, K., Bindslev-Jensen, C., Burks, W., du Toit, G., Ebisawa, M., Eigenmann, P., Knol, E., Mäkelä, Mika, Nadeau, K. C., O'Mahony, L., Papadopoulos, N., Poulsen, L. K., Sackesen, C., Sampson, H., Santos, A. F., van Ree, R., Timmermans, F., Sheikh, A., Clinicum, Department of Dermatology, Allergology and Venereology, and HUS Inflammation Center
- Subjects
safety ,ORAL TOLERANCE INDUCTION ,food allergy ,PEANUT ALLERGY ,desensitization ,CHILDREN ,CONTROLLED-TRIAL ,DOUBLE-BLIND ,EGG ALLERGY ,SUBLINGUAL IMMUNOTHERAPY ,3121 General medicine, internal medicine and other clinical medicine ,sustained unresponsiveness ,COWS MILK ALLERGY ,allergen immunotherapy ,ANAPHYLACTIC REACTIONS - Abstract
Background: The European Academy of Allergy and Clinical Immunology (EAACI) is developing Guidelines for Allergen Immunotherapy (AIT) for IgE-mediated Food Allergy. To inform the development of clinical recommendations, we sought to critically assess evidence on the effectiveness, safety and cost-effectiveness of AIT in the management of food allergy. Methods: We undertook a systematic review and meta-analysis that involved searching nine international electronic databases for randomized controlled trials (RCTs) and nonrandomized studies (NRS). Eligible studies were independently assessed by two reviewers against predefined eligibility criteria. The quality of studies was assessed using the Cochrane Risk of Bias tool for RCTs and the Cochrane ACROBAT-NRS tool for quasi-RCTs. Random-effects meta-analyses were undertaken, with planned subgroup and sensitivity analyses. Results: We identified 1814 potentially relevant papers from which we selected 31 eligible studies, comprising of 25 RCTs and six NRS, studying a total of 1259 patients. Twenty-five trials evaluated oral immunotherapy (OIT), five studies investigated sublingual immunotherapy, and one study evaluated epicutaneous immunotherapy. The majority of these studies were in children. Twenty-seven studies assessed desensitization, and eight studies investigated sustained unresponsiveness postdiscontinuation of AIT. Meta-analyses demonstrated a substantial benefit in terms of desensitization (risk ratio (RR) = 0.16, 95% CI 0.10, 0.26) and suggested, but did not confirm sustained unresponsiveness (RR = 0.29, 95% CI 0.08, 1.13). Only one study reported on disease-specific quality of life (QoL), which reported no comparative results between OIT and control group. Meta-analyses revealed that the risk of experiencing a systemic adverse reaction was higher in those receiving AIT, with a more marked increase in the risk of local adverse reactions. Sensitivity analysis excluding those studies judged to be at high risk of bias demonstrated the robustness of summary estimates of effectiveness and safety of AIT for food allergy. None of the studies reported data on health economic analyses. Conclusions: AIT may be effective in raising the threshold of reactivity to a range of foods in children with IgE-mediated food allergy whilst receiving (i.e. desensitization) and post-discontinuation of AIT. It is, however, associated with a modest increased risk in serious systemic adverse reactions and a substantial increase in minor local adverse reactions. More data are needed in relation to adults, long term effects, the impact on QoL and the cost-effectiveness of AIT.
- Published
- 2017
5. EAACI molecular allergology user's guide
- Author
-
Matricardi, P.M., Kleine-Tebbe, J., Hoffmann, H.J., Valenta, R., Hilger, C., Hofmaier, S., Aalberse, R.C., Agache, I., Asero, R., Ballmer-Weber, B., Barber, D., Beyer, K., Biedermann, T., Bilo, M.B., Blank, S., Bohle, B., Bosshard, P.P., Breiteneder, H., Brough, H.A., Caraballo, L.R., Caubet, J.C., Crameri, R., Davies, J.M., Douladiris, N., Ebisawa, M., EIgenmann, P.A., Fernandez-Rivas, M., Ferreira, F., Gadermaier, G., Glatz, M., Hamilton, R.G., Hawranek, T., Hellings, P.W., Hoffmann-Sommergruber, K., Jakob, T., Jappe, U., Jutel, M., Kamath, S.D., Knol, E.F., Korosec, P., Kuehn, A., Lack, G., Lopata, A.L., Makela, M.J., Morisset, M., Niederberger, V., Nowak-Węgrzyn, A.H., Papadopoulos, N.G., Pastorello, E.A., Pauli, G., Platts-Mills, T., Posa, D., Poulsen, L.K., Raulf, M., Sastre, J., Scala, E., Schmid, J.M., Schmid-Grendelmeier, P., van Hage, M., van Ree, R., Vieths, S., Weber, R., Wickman, M., Muraro, A., and Ollert, M.
- Subjects
Ige ,Ige Cross-reactivity ,Allergy ,Allergy Diagnosis ,Anaphylaxis ,Asthma ,Atopic Dermatitis ,Component-resolved Diagnosis ,Diagnosis ,Diagnostic Algorithms ,Food Allergy ,Guidelines ,Lipocalins ,Microarray ,Molecular Allergology ,Non-spec ,food and beverages - Abstract
The availability of allergen molecules ('components') from several protein families has advanced our understanding of immunoglobulin E (IgE)-mediated responses and enabled 'component-resolved diagnosis' (CRD). The European Academy of Allergy and Clinical Immunology (EAACI) Molecular Allergology User's Guide (MAUG) provides comprehensive information on important allergens and describes the diagnostic options using CRD. Part A of the EAACI MAUG introduces allergen molecules, families, composition of extracts, databases, and diagnostic IgE, skin, and basophil tests. Singleplex and multiplex IgE assays with components improve both sensitivity for low-abundance allergens and analytical specificity; IgE to individual allergens can yield information on clinical risks and distinguish cross-reactivity from true primary sensitization. Part B discusses the clinical and molecular aspects of IgE-mediated allergies to foods (including nuts, seeds, legumes, fruits, vegetables, cereal grains, milk, egg, meat, fish, and shellfish), inhalants (pollen, mold spores, mites, and animal dander), and Hymenoptera venom. Diagnostic algorithms and short case histories provide useful information for the clinical workup of allergic individuals targeted for CRD. Part C covers protein families containing ubiquitous, highly cross-reactive panallergens from plant (lipid transfer proteins, polcalcins, PR-10, profilins) and animal sources (lipocalins, parvalbumins, serum albumins, tropomyosins) and explains their diagnostic and clinical utility. Part D lists 100 important allergen molecules. In conclusion, IgE-mediated reactions and allergic diseases, including allergic rhinoconjunctivitis, asthma, food reactions, and insect sting reactions, are discussed from a novel molecular perspective. The EAACI MAUG documents the rapid progression of molecular allergology from basic research to its integration into clinical practice, a quantum leap in the management of allergic patients.
- Published
- 2016
6. The urgent need for a harmonized severity scoring system for acute allergic reactions.
- Author
-
Muraro, A., Fernandez‐Rivas, M., Beyer, K., Cardona, V., Clark, A., Eller, E., Hourihane, J. O'B., Jutel, M., Sheikh, A., Agache, I., Allen, K. J., Angier, E., Ballmer‐Weber, B., Bilò, M. B., Bindslev‐Jensen, C., Camargo, Jr, C. A., Cianferoni, A., DunnGalvin, A., Eigenmann, P. A., and Halken, S.
- Subjects
ALLERGIES ,ANAPHYLAXIS ,PUBLIC health ,FOOD allergy ,ALLERGENS ,MEDICAL personnel ,PATIENTS ,THERAPEUTICS - Abstract
Abstract: The accurate assessment and communication of the severity of acute allergic reactions are important to patients, clinicians, researchers, the food industry, and public health and regulatory authorities. Severity has different meanings to different stakeholders with patients and clinicians rating the significance of particular symptoms very differently. Many severity scoring systems have been generated, most focusing on the severity of reactions following exposure to a limited group of allergens. They are heterogeneous in format, none has used an accepted developmental approach, and none has been validated. Their wide range of outcome formats has led to difficulties with interpretation and application. Therefore, there is a persisting need for an appropriately developed and validated severity scoring system for allergic reactions that work across the range of allergenic triggers and address the needs of different stakeholder groups. We propose a novel approach to develop and then validate a harmonized scoring system for acute allergic reactions, based on a data‐driven method that is informed by clinical and patient experience and other stakeholders’ perspectives. We envisage two formats: (i) a numerical score giving a continuum from mild to severe reactions that are clinically meaningful and are useful for allergy healthcare professionals and researchers, and (ii) a three‐grade‐based ordinal format that is simple enough to be used and understood by other professionals and patients. Testing of reliability and validity of the new approach in a range of settings and populations will allow eventual implementation of a standardized scoring system in clinical studies and routine practice. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
7. How does dose impact on the severity of food‐induced allergic reactions, and can this improve risk assessment for allergenic foods?
- Author
-
Dubois, A. E. J., Turner, P. J., Hourihane, J., Ballmer‐Weber, B., Beyer, K., Chan, C.‐H., Gowland, M. H., O'Hagan, S., Regent, L., Remington, B., Schnadt, S., Stroheker, T., and Crevel, R. W. R.
- Subjects
FOOD allergy ,HEALTH risk assessment ,ALLERGENS ,FOOD allergy prevention ,TREATMENT of Food allergies - Abstract
Abstract: Quantitative risk assessment (QRA) for food allergens has made considerable progress in recent years, yet acceptability of its outcomes remains stymied because of the limited extent to which it has been possible to incorporate severity as a variable. Reaction severity, particularly following accidental exposure, depends on multiple factors, related to the allergen, the host and any treatments, which might be administered. Some of these factors are plausibly still unknown. Quantitative risk assessment shows that limiting exposure through control of dose reduces the rates of reactions in allergic populations, but its impact on the relative frequency of severe reactions at different doses is unclear. Food challenge studies suggest that the relationship between dose of allergenic food and reaction severity is complex even under relatively controlled conditions. Because of these complexities, epidemiological studies provide very limited insight into this aspect of the dose‐response relationship. Emerging data from single‐dose challenges suggest that graded food challenges may overestimate the rate of severe reactions. It may be necessary to generate new data (such as those from single‐dose challenges) to reliably identify the effect of dose on severity for use in QRA. Success will reduce uncertainty in the susceptible population and improve consumer choice. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
8. Fish oil in infancy protects against food allergy in Iceland—Results from a birth cohort study.
- Author
-
Clausen, M., Jonasson, K., Keil, T., Beyer, K., and Sigurdardottir, S. T.
- Subjects
FISH oils ,FOOD allergy ,ALLERGIES ,PREGNANCY ,LACTATION ,INFANTS ,PREVENTIVE medicine - Abstract
Abstract: Background: Consumption of oily fish or fish oil during pregnancy, lactation and infancy has been linked to a reduction in the development of allergic diseases in childhood. Methods: In an observational study, Icelandic children (n = 1304) were prospectively followed from birth to 2.5 years with detailed questionnaires administered at birth and at 1 and 2 years of age, including questions about fish oil supplementation. Children with suspected food allergy were invited for physical examinations, allergic sensitization tests, and a double‐blind, placebo‐controlled food challenge if the allergy testing or clinical history indicated food allergy. The study investigated the development of sensitization to food and confirmed food allergy according to age and frequency of postnatal fish oil supplementation using proportional hazards modelling. Results: The incidence of diagnosed food sensitization was significantly lower in children who received regular fish oil supplementation (relative risk: 0.51, 95% confidence interval: 0.32‐0.82). The incidence of challenge‐confirmed food allergy was also reduced, although not statistically significant (0.57, 0.30‐1.12). Children who began to receive fish oil in their first half year of life were significantly more protected than those who began later (P = .045 for sensitization, P = .018 for allergy). Indicators of allergy severity decreased with increased fish oil consumption (P = .013). Adjusting for parent education and allergic family history did not change the results. Conclusion: Postnatal fish oil consumption is associated with decreased food sensitization and food allergies in infants and may provide an intervention strategy for allergy prevention. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
9. EAACI Guidelines on allergen immunotherapy: IgE‐mediated food allergy.
- Author
-
Pajno, G. B., Fernandez‐Rivas, M., Arasi, S., Roberts, G., Akdis, C. A., Alvaro‐Lozano, M., Beyer, K., Bindslev‐Jensen, C., Burks, W., Ebisawa, M., Eigenmann, P., Knol, E., Nadeau, K. C., Poulsen, L. K., van Ree, R., Santos, A. F., du Toit, G., Dhami, S., Nurmatov, U., and Boloh, Y.
- Subjects
FOOD allergy ,IMMUNOTHERAPY ,CLINICAL immunology ,ALLERGY treatment ,ANTIHISTAMINES ,ALLERGENS - Abstract
Abstract: Food allergy can result in considerable morbidity, impairment of quality of life, and healthcare expenditure. There is therefore interest in novel strategies for its treatment, particularly food allergen immunotherapy (FA‐AIT) through the oral (OIT), sublingual (SLIT), or epicutaneous (EPIT) routes. This Guideline, prepared by the European Academy of Allergy and Clinical Immunology (EAACI) Task Force on Allergen Immunotherapy for IgE‐mediated Food Allergy, aims to provide evidence‐based recommendations for active treatment of IgE‐mediated food allergy with FA‐AIT. Immunotherapy relies on the delivery of gradually increasing doses of specific allergen to increase the threshold of reaction while on therapy (also known as desensitization) and ultimately to achieve post‐discontinuation effectiveness (also known as tolerance or sustained unresponsiveness). Oral FA‐AIT has most frequently been assessed: here, the allergen is either immediately swallowed (OIT) or held under the tongue for a period of time (SLIT). Overall, trials have found substantial benefit for patients undergoing either OIT or SLIT with respect to efficacy during treatment, particularly for cow's milk, hen's egg, and peanut allergies. A benefit post‐discontinuation is also suggested, but not confirmed. Adverse events during FA‐AIT have been frequently reported, but few subjects discontinue FA‐AIT as a result of these. Taking into account the current evidence, FA‐AIT should only be performed in research centers or in clinical centers with an extensive experience in FA‐AIT. Patients and their families should be provided with information about the use of FA‐AIT for IgE‐mediated food allergy to allow them to make an informed decision about the therapy. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
10. Hen's egg allergen in house and bed dust is significantly increased after hen's egg consumption-A pilot study.
- Author
-
Trendelenburg, V., Tschirner, S., Niggemann, B., and Beyer, K.
- Subjects
EGGS ,ALLERGENS ,ANTIGENS ,ALLERGIES ,FOOD allergy - Abstract
Environmental exposure to food allergens may be a risk factor for cutaneous sensitization. Previous studies could detect peanut allergen in house dust. In this pilot study, we wanted to investigate whether hen's egg allergen is detectable in house dust collected from different household areas and whether levels are increased after intentional hen's egg consumption. Hen's egg protein levels of dust samples were measured using ELISA. In 8 of 8 households, hen's egg was detectable in dust samples of eating area and bed. Forty-eight hours after intentional hen's egg consumption, hen's egg protein levels were significantly increased in both. Still, further research is necessary to investigate whether hen's egg allergen in house and bed dust plays a role in sensitization via skin. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
11. Natural tolerance development in cow's milk allergic children: IgE and IgG4 epitope binding.
- Author
-
Caubet, J. C., Lin, J., Ahrens, B., Gimenez, G., Bardina, L., Niggemann, B., Sampson, H. A., and Beyer, K.
- Subjects
TOLERATION ,MILK allergy ,CHILDREN ,IMMUNOGLOBULIN E ,EPITOPES - Abstract
Background Although most of cow's milk ( CM) allergic children will outgrow their allergy, the pathomechanism of the natural development of tolerance remains poorly understood. It has been suggested that the balance between milk-specific IgE and IgG4 plays a major role. Objective We aimed to investigate differences in IgE and IgG4 antibody binding to CM epitopes between patients with persistent CM allergy ( CMA) and those that naturally became tolerant. Methods Sera from 35 children with proven CMA (median age at inclusion of 10 months) were analyzed retrospectively; 22 patients have become tolerant (median age at tolerance acquisition of 51 months) during the study period as confirmed by a negative oral food challenge. IgE and IgG4 binding to sequential epitopes derived from five major CM proteins were measured with a peptide microarray-based immunoassay. Results At baselines, greater intensity and broader diversity of IgE and IgG4 binding have been found in children with persistent CMA beyond 5 years of age compared to patients with transient CMA. Moreover, children with transient CMA had IgE and IgG4 antibodies that more often recognized the same epitopes, compared to those with persistent CMA. From baseline to the time of tolerance development, both IgE and IgG4 binding intensity decreased significantly, particularly in areas of α-s- and β-casein ( P<.01, false discovery rate [ FDR]<.1). Interestingly, differences between IgE and IgG4 binding intensity to CM peptides decreased when the patients became tolerant. Conclusions Our results suggest that the overlap between IgE and IgG4 might be important in natural tolerance acquisition. Further studies are needed to confirm our data and can eventually lead to development of more targeted treatment of food allergy. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
12. IgE-Mediated food allergy diagnosis: Current status and new perspectives
- Author
-
Asero R., Ballmer-Weber B.K., Beyer K., Conti A., Dubakiene R., Fernandez-Rivas M., Hoffmann-Sommergruber K., Lidholm J., Mustakov T., Oude Elberink J.N.G., Pumphrey R.S.H., Stahl Skov P., van Ree R., Vlieg- Boerstra B.J., and Hiller R.
- Subjects
Diagnosis ,Food allergy ,IgE ,Skin tests - Abstract
In June 2005, the work of the EU Integrated Project EuroPrevall was started. EuroPrevall is the largest research project on food allergy ever performed in Europe. Major aims of the project are to generate for the first time reliable data on the prevalence of food allergies across Europe and on the natural course of food allergy development in infants. Improvement of in vitro diagnosis of food allergies is another important aim of the project. The present review summarizes current knowledge about the clinical presentation of food allergy and critically reviews available diagnostic tools at the beginning of the project period. A major problem in diagnosis is a relatively poor ,clinical specificity, i. e. both positive skin tests and in vitro tests for specific IgE are frequent in sensitized subjects without food allergy symptoms. So far, no in vitro test reliably predicts clinical food allergy. EuroPrevall aims at improving the predictive value of such tests by proceeding from diagnosis based on allergen extracts to purified allergen molecules, taking into account the affinity of the IgEallergen interaction, and evaluating the potential of biological ....................
- Published
- 2007
13. Performance of a polymer coated silicon microarray for simultaneous detection of food allergen-specific IgE and IgG4.
- Author
-
Sievers, S., Cretich, M., Gagni, P., Ahrens, B., Grishina, G., Sampson, H. A., Niggemann, B., Chiari, M., and Beyer, K.
- Subjects
FOOD allergy ,ALLERGENS ,FOOD substitutes ,GASTRONOMY ,BASIC needs - Abstract
Background Microarray-based component-resolved diagnostics (CRD) has become an accepted tool to detect allergen-specific IgE sensitization towards hundreds of allergens in parallel from one drop of serum. Nevertheless, specificity and sensitivity as well as a simultaneous detection of allergen-specific IgG
4 , as a potential parameter for tolerance development, remain to be optimized. Objective We applied the recently introduced silicon chip coated with a functional polymer named copoly(DMA-NAS-MAPS) to the simultaneous detection of food allergen-specific IgE and IgG4 , and compared it with ImmunoCAP and ImmunoCAP ISAC. Inter- and intraslide variation, linearity of signal and working range, sensitivity and application of internal calibrations for IgE and IgG4 were assessed. Methods Native and recombinant allergenic proteins from hen's egg and cow's milk were spotted on silicon chips coated with copoly(DMA-NAS-MAPS) along with known concentrations for human IgE and IgG4 . A serum pool and 105 patient samples were assessed quantitatively and semi-quantitatively with the ImmunoCAP and ImmunoCAP ISAC and correlated with IgE- and IgG4 -specific fluorescence on silicon microarrays. Results Allergen-specific IgE and IgG4 were detected in parallel using two fluorescent dyes with no crosstalk. Results from the ImmunoCAP correlated better with microarray fluorescence than with ImmunoCAP ISAC except for the allergen ovomucoid. The working range of the silicon microarray for total hen's egg-specific IgE was comparable to the range of 0.1 to >100 kUA /L of the ImmunoCAP system, whereas for total cow's milk, the silicon microarray was less sensitive. Detectable allergen-specific IgG4 could be determined only for low concentrations, but still correlated positively with ImmunoCAP results. Conclusions We confirmed the ability of the polymer coated silicon microarray to be comparably sensitive to the ImmunoCAP ISAC for various food allergens. This suggests that the copoly(DMA-NAS-MAPS) microarray is a low-cost, self-producible alternative to the commercial ImmunoCAP ISAC in allergy research. [ABSTRACT FROM AUTHOR]- Published
- 2017
- Full Text
- View/download PDF
14. Ana o 3-specific IgE is a good predictor for clinically relevant cashew allergy in children.
- Author
-
Lange, L., Lasota, L., Finger, A., Vlajnic, D., Büsing, S., Meister, J., Broekaert, I., Pfannenstiel, C., Friedrichs, F., Price, M., Trendelenburg, V., Niggemann, B., and Beyer, K.
- Subjects
ALLERGY diagnosis ,IMMUNOGLOBULIN E ,CASHEW nuts ,FOOD allergy ,ALBUMINS - Abstract
Introduction Component-resolved diagnostics using specific IgE to 2 S albumins has shown to be a valuable new option in diagnostic procedure. Ana o 3 is a 2 S albumin from cashew. The aim of this study was to investigate the role of Ana o 3-specific serum IgE in the diagnosis of cashew allergy and to identify cut-off levels to replace oral food challenges. Moreover, the value of additional determination of total IgE has been investigated. Methods In a multicentre study, we analysed specific IgE to cashew extract and Ana o 3 as well as total IgE in children with suspected cashew allergy using the Immuno CAP- FEIA and a standardized diagnostic procedure including oral challenges where indicated. Results A total of 61 patients were included in the study. Forty-two were allergic to cashew, and 19 were tolerant. In receiver operating curves, Ana o 3 discriminates between allergic and tolerant children better than cashew-specific IgE with an area under the curve of 0.94 vs 0.78. The ratio of Ana o 3-specific IgE to total IgE did not further improve the diagnostic procedure. Probability curves for Ana o 3-specific IgE have been calculated, and a 95% probability could be estimated at 2.0 kU/l. Conclusion Specific IgE to Ana o 3 is a valuable tool for the diagnosis of cashew allergy. Considering its positive predictive value, it might allow to make a considerable number of oral challenges superfluous. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
15. A new framework for the documentation and interpretation of oral food challenges in population-based and clinical research.
- Author
-
Grabenhenrich, L. B., Reich, A., Bellach, J., Trendelenburg, V., Sprikkelman, A. B., Roberts, G., Grimshaw, K. E. C., Sigurdardottir, S., Kowalski, M. L., Papadopoulos, N. G., Quirce, S., Dubakiene, R., Niggemann, B., Fernández-Rivas, M., Ballmer-Weber, B., Ree, R., Schnadt, S., Mills, E. N. C., Keil, T., and Beyer, K.
- Subjects
ALLERGY treatment ,FOOD allergy ,MEDICAL terminology ,SYMPTOMS ,MEDICAL communication ,MEDICAL decision making - Abstract
Background The conduct of oral food challenges as the preferred diagnostic standard for food allergy ( FA) was harmonized over the last years. However, documentation and interpretation of challenge results, particularly in research settings, are not sufficiently standardized to allow valid comparisons between studies. Our aim was to develop a diagnostic toolbox to capture and report clinical observations in double-blind placebo-controlled food challenges ( DBPCFC). Methods A group of experienced allergists, paediatricians, dieticians, epidemiologists and data managers developed generic case report forms and standard operating procedures for DBPCFCs and piloted them in three clinical centres. The follow-up of the EuroPrevall/i FAAM birth cohort and other i FAAM work packages applied these methods. Recommendations A set of newly developed questionnaire or interview items capture the history of FA. Together with sensitization status, this forms the basis for the decision to perform a DBPCFC, following a standardized decision algorithm. A generic form including details about severity and timing captures signs and symptoms observed during or after the procedures. In contrast to the commonly used dichotomous outcome FA vs no FA, the allergy status is interpreted in multiple categories to reflect the complexity of clinical decision-making. Conclusion The proposed toolbox sets a standard for improved documentation and harmonized interpretation of DBPCFCs. By a detailed documentation and common terminology for communicating outcomes, these tools hope to reduce the influence of subjective judgment of supervising physicians. All forms are publicly available for further evolution and free use in clinical and research settings. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
16. Genomewide association study of peanut allergy reproduces association with amino acid polymorphisms in HLA- DRB1.
- Author
-
Martino, D. J., Ashley, S., Koplin, J., Ellis, J., Saffery, R., Dharmage, S. C., Gurrin, L., Matheson, M. C., Kalb, B., Marenholz, I., Beyer, K., Lee, Y. ‐ A., Hong, X., Wang, X., Vukcevic, D., Motyer, A., Leslie, S., Allen, K. J., and Ferreira, M. A. R.
- Subjects
PEANUT allergy ,ALLERGIES ,SINGLE nucleotide polymorphisms ,HLA histocompatibility antigens ,ALLELES ,AMINO acids ,GENETICS - Abstract
Background Genetic variants for IgE-mediated peanut allergy are yet to be fully characterized and to date only one genomewide association study ( GWAS) has been published. Objective To identify genetic variants associated with challenge-proven peanut allergy. Methods We carried out a GWAS comparing 73 infants with challenge-proven IgE-mediated peanut allergy against 148 non-allergic infants (all ~ 1 year old). We tested a total of 3.8 million single nucleotide polymorphisms, as well as imputed HLA alleles and amino acids. Replication was assessed by de novo genotyping in a panel of additional 117 cases and 380 controls, and in silico testing in two independent GWAS cohorts. Results We identified 21 independent associations at P ≤ 5 × 10
−5 but were unable to replicate these. The most significant HLA association was the previously reported amino acid variant located at position 71, within the peptide-binding groove of HLA- DRB1 ( P = 2 × 10−4 ). Our study therefore reproduced previous findings for the association between peanut allergy and HLA- DRB1 in this Australian population. Conclusions and Clinical Relevance Genetic determinants for challenge-proven peanut allergy include alleles at the HLA- DRB1 locus. [ABSTRACT FROM AUTHOR]- Published
- 2017
- Full Text
- View/download PDF
17. Nahrungsmittelallergien und -intoleranzen : Immunologie - Diagnostik - Therapie - Prophylaxe
- Author
-
Beyer, K., Jäger, L., Beyer, K., and Jäger, L.
- Subjects
- Food allergy
- Abstract
Der vollständige, aktualisierte und ergänzte Überblick über Entstehung, Epidemiologie, Diagnostik, Therapie und Prophylaxe von Nahrungsmittelallergien mit allen Nahrungsmittelallergenen von A-Z. Dazu Testmethoden, Kreuzreaktivität, Nahrungsmittelzusatzstoffe und Informationen zu den Risiken genmanipulierter Nahrungsmittel.
- Published
- 2008
18. Can we identify patients at risk of life-threatening allergic reactions to food?
- Author
-
Turner, P. J., Baumert, J. L., Beyer, K., Boyle, R. J., Chan, C.‐H., Clark, A. T., Crevel, R. W. R., DunnGalvin, A., Fernández‐Rivas, M., Gowland, M. H., Grabenhenrich, L., Hardy, S., Houben, G. F., O'B Hourihane, J., Muraro, A., Poulsen, L. K., Pyrz, K., Remington, B. C., Schnadt, S., and Ree, R.
- Subjects
FOOD allergy ,ANAPHYLAXIS ,ALLERGENS ,ALLERGIES ,PHYSIOLOGICAL effects of food - Abstract
Anaphylaxis has been defined as a 'severe, life-threatening generalized or systemic hypersensitivity reaction'. However, data indicate that the vast majority of food-triggered anaphylactic reactions are not life-threatening. Nonetheless, severe life-threatening reactions do occur and are unpredictable. We discuss the concepts surrounding perceptions of severe, life-threatening allergic reactions to food by different stakeholders, with particular reference to the inclusion of clinical severity as a factor in allergy and allergen risk management. We review the evidence regarding factors that might be used to identify those at most risk of severe allergic reactions to food, and the consequences of misinformation in this regard. For example, a significant proportion of food-allergic children also have asthma, yet almost none will experience a fatal food-allergic reaction; asthma is not, in itself, a strong predictor for fatal anaphylaxis. The relationship between dose of allergen exposure and symptom severity is unclear. While dose appears to be a risk factor in at least a subgroup of patients, studies report that individuals with prior anaphylaxis do not have a lower eliciting dose than those reporting previous mild reactions. It is therefore important to consider severity and sensitivity as separate factors, as a highly sensitive individual will not necessarily experience severe symptoms during an allergic reaction. We identify the knowledge gaps that need to be addressed to improve our ability to better identify those most at risk of severe food-induced allergic reactions. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
19. EAACI Molecular Allergology User's Guide.
- Author
-
Matricardi, P. M., Kleine-Tebbe, J., Hoffmann, H. J., Valenta, R., Hilger, C., Hofmaier, S., Aalberse, R. C., Agache, I., Asero, R., Ballmer-Weber, B., Barber, D., Beyer, K., Biedermann, T., Bilò, M. B., Blank, S., Bohle, B., Bosshard, P. P., Breiteneder, H., Brough, H. A., and Caraballo, L.
- Subjects
ALLERGY diagnosis ,CROSS reactions (Immunology) ,STEROL carrier proteins ,PROFILIN ,TROPOMYOSINS ,PARVALBUMINS ,SERUM albumin ,ANAPHYLAXIS - Abstract
The availability of allergen molecules ('components') from several protein families has advanced our understanding of immunoglobulin E (IgE)-mediated responses and enabled 'component-resolved diagnosis' ( CRD). The European Academy of Allergy and Clinical Immunology ( EAACI) Molecular Allergology User's Guide ( MAUG) provides comprehensive information on important allergens and describes the diagnostic options using CRD. Part A of the EAACI MAUG introduces allergen molecules, families, composition of extracts, databases, and diagnostic IgE, skin, and basophil tests. Singleplex and multiplex IgE assays with components improve both sensitivity for low-abundance allergens and analytical specificity; IgE to individual allergens can yield information on clinical risks and distinguish cross-reactivity from true primary sensitization. Part B discusses the clinical and molecular aspects of IgE-mediated allergies to foods (including nuts, seeds, legumes, fruits, vegetables, cereal grains, milk, egg, meat, fish, and shellfish), inhalants (pollen, mold spores, mites, and animal dander), and Hymenoptera venom. Diagnostic algorithms and short case histories provide useful information for the clinical workup of allergic individuals targeted for CRD. Part C covers protein families containing ubiquitous, highly cross-reactive panallergens from plant (lipid transfer proteins, polcalcins, PR-10, profilins) and animal sources (lipocalins, parvalbumins, serum albumins, tropomyosins) and explains their diagnostic and clinical utility. Part D lists 100 important allergen molecules. In conclusion, IgE-mediated reactions and allergic diseases, including allergic rhinoconjunctivitis, asthma, food reactions, and insect sting reactions, are discussed from a novel molecular perspective. The EAACI MAUG documents the rapid progression of molecular allergology from basic research to its integration into clinical practice, a quantum leap in the management of allergic patients. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
20. Position paper of the EAACI: food allergy due to immunological cross-reactions with common inhalant allergens.
- Author
-
Werfel, T., Asero, R., Ballmer‐Weber, B. K., Beyer, K., Enrique, E., Knulst, A. C., Mari, A., Muraro, A., Ollert, M., Poulsen, L. K., Vieths, S., Worm, M., and Hoffmann‐Sommergruber, K.
- Subjects
FOOD allergy ,CROSS reactions (Immunology) ,IMMUNOGLOBULIN E ,ALLERGENS ,IMMUNOTHERAPY ,ALLERGIC rhinitis ,GASTROINTESTINAL diseases - Abstract
In older children, adolescents, and adults, a substantial part of all IgE-mediated food allergies is caused by cross-reacting allergenic structures shared by inhalants and foods. IgE stimulated by a cross-reactive inhalant allergen can result in diverse patterns of allergic reactions to various foods. Local, mild, or severe systemic reactions may occur already after the first consumption of a food containing a cross-reactive allergen. In clinical practice, clinically relevant sensitizations are elucidated by skin prick testing or by the determination of specific IgE in vitro. Component-resolved diagnosis may help to reach a diagnosis and may predict the risk of a systemic reaction. Allergy needs to be confirmed in cases of unclear history by oral challenge tests. The therapeutic potential of allergen immunotherapy with inhalant allergens in pollen-related food allergy is not clear, and more placebo-controlled studies are needed. As we are facing an increasing incidence of pollen allergies, a shift in sensitization patterns and changes in nutritional habits, and the occurrence of new, so far unknown allergies due to cross-reactions are expected. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
21. Precautionary allergen labelling: perspectives from key stakeholder groups.
- Author
-
DunnGalvin, A., Chan, C.‐H., Crevel, R., Grimshaw, K., Poms, R., Schnadt, S., Taylor, S. L., Turner, P., Allen, K. J., Austin, M., Baka, A., Baumert, J. L., Baumgartner, S., Beyer, K., Bucchini, L., Fernández‐Rivas, M., Grinter, K., Houben, G. F., Hourihane, J., and Kenna, F.
- Subjects
FOOD allergy prevention ,FOOD industry ,CONSUMERS ,MEDICAL personnel ,CONSUMER psychology ,STAKEHOLDERS ,HEALTH - Abstract
Precautionary allergen labelling ( PAL) was introduced by the food industry to help manage and communicate the possibility of reaction from the unintended presence of allergens in foods. However, in its current form, PAL is counterproductive for consumers with food allergies. This review aims to summarize the perspectives of all the key stakeholders (including clinicians, patients, food industry and regulators), with the aim of defining common health protection and risk minimization goals. The lack of agreed reference doses has resulted in inconsistent application of PAL by the food industry and in levels of contamination that prompt withdrawal action by enforcement officers. So there is a poor relationship between the presence or absence of PAL and actual reaction risk. This has led to a loss of trust in PAL, reducing the ability of consumers with food allergies to make informed choices. The result has been reduced avoidance, reduced quality of life and increased risk-taking by consumers who often ignore PAL. All contributing stakeholders agree that PAL must reflect actual risk. PAL should be transparent and consistent with rules underpinning decision-making process being communicated clearly to all stakeholders. The use of PAL should indicate the possible, unintended presence of an allergen in a consumed portion of a food product at or above any proposed action level. This will require combined work by all stakeholders to ensure everyone understands the approach and its limitations. Consumers with food allergy then need to be educated to undertake individualized risk assessments in relation to any PAL present. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
22. Factors augmenting allergic reactions.
- Author
-
Niggemann, B. and Beyer, K.
- Subjects
- *
ANAPHYLAXIS , *NONSTEROIDAL anti-inflammatory agents , *BODY temperature , *ANTIHISTAMINES , *FOOD allergy - Abstract
Elicitors of anaphylactic reactions are any sources of protein with allergenic capacity. However, not all allergic reactions end up in the most severe form of anaphylaxis. Augmenting factors may explain why certain conditions lead to anaphylaxis. Augmenting factors may exhibit three effects: lowering the threshold, increasing the severity, and reversing acquired clinical tolerance. Common augmenting factors are physical exercise, menstruation, NSAIDs, alcohol, body temperature, acute infections, and antacids. Therapeutic options may address causative, preventive, pragmatic, or symptomatic considerations: avoid the eliciting food, take an antihistamine before any situation with a possible risk of augmentation, separate food and sport (at least for 2 h), and carry an adrenaline autoinjector at all times. Individual patterns include summation effects and specific patterns. In conclusion, in the case of a suggestive history but a negative oral challenge, one should consider the possible involvement of augmenting factors; after anaphylactic reactions, always ask for possible augmentation and other risk factors during the recent past; if augmentation is suspected, oral food challenges should be performed in combination with augmenting factors; and in the future, standardized challenge protocols including augmenting factors should be established. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
23. First European data from the network of severe allergic reactions ( NORA).
- Author
-
Worm, M., Moneret‐Vautrin, A., Scherer, K., Lang, R., Fernandez‐Rivas, M., Cardona, V., Kowalski, M. L., Jutel, M., Poziomkowska‐Gesicka, I., Papadopoulos, N. G., Beyer, K., Mustakov, T., Christoff, G., Bilò, M. B., Muraro, A., Hourihane, J. O. B., and Grabenhenrich, L. B.
- Subjects
ALLERGY diagnosis ,ALLERGY treatment ,ANAPHYLAXIS ,HISTORY of medicine ,FOOD allergy ,ACQUISITION of data ,MEDICAL registries - Abstract
Background Occurrence, elicitors and treatment of severe allergic reactions are recognized and reported differently between countries. We aimed to collect standardized data throughout Europe on anaphylaxis referred for diagnosis and counselling. Methods Tertiary allergy, dermatology and paediatric units in 10 European countries took part in this pilot phase of the first European Anaphylaxis Registry, from June 2011 to March 2014. An online questionnaire was used to collect data on severe allergic reactions based on the medical history and diagnostics. Results Fifty-nine centres reported 3333 cases of anaphylaxis, with 26.7% below 18 years of age. Allergic reactions were mainly caused by food (children and adults 64.9% and 20.2%, respectively) and insect venom (20.2% and 48.2%) and less often by drugs (4.8% and 22.4%). Most reactions occurred within 30 min of exposure (80.5%); a delay of 4+ hours was mainly seen in drug anaphylaxis (6.7%). Symptom patterns differed by elicitor, with the skin being affected most often (84.1%). A previous, usually milder reaction to the same allergen was reported by 34.2%. The mainstay of first-line treatment by professionals included corticoids (60.4%) and antihistamines (52.8%). Only 13.7% of lay- or self-treated reactions to food and 27.6% of insect anaphylaxis received on-site adrenaline. Conclusion This pilot phase of a pan-European registry for severe allergic reactions provides for the first time data on anaphylaxis throughout Europe, demonstrates its potential functionality and allows a comparison of symptom patterns, elicitors and treatment habits between referral centres and countries. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
24. EAACI Food Allergy and Anaphylaxis Guidelines: diagnosis and management of food allergy.
- Author
-
Muraro, A., Werfel, T., Hoffmann‐Sommergruber, K., Roberts, G., Beyer, K., Bindslev‐Jensen, C., Cardona, V., Dubois, A., duToit, G., Eigenmann, P., Fernandez Rivas, M., Halken, S., Hickstein, L., Høst, A., Knol, E., Lack, G., Marchisotto, M. J., Niggemann, B., Nwaru, B. I., and Papadopoulos, N. G.
- Subjects
ANAPHYLAXIS ,FOOD allergy ,MEDICAL laws ,EPIDEMIOLOGY ,PRIMARY care ,MANAGEMENT - Abstract
Food allergy can result in considerable morbidity, impact negatively on quality of life, and prove costly in terms of medical care. These guidelines have been prepared by the European Academy of Allergy and Clinical Immunology's ( EAACI) Guidelines for Food Allergy and Anaphylaxis Group, building on previous EAACI position papers on adverse reaction to foods and three recent systematic reviews on the epidemiology, diagnosis, and management of food allergy, and provide evidence-based recommendations for the diagnosis and management of food allergy. While the primary audience is allergists, this document is relevant for all other healthcare professionals, including primary care physicians, and pediatric and adult specialists, dieticians, pharmacists and paramedics. Our current understanding of the manifestations of food allergy, the role of diagnostic tests, and the effective management of patients of all ages with food allergy is presented. The acute management of non-life-threatening reactions is covered in these guidelines, but for guidance on the emergency management of anaphylaxis, readers are referred to the related EAACI Anaphylaxis Guidelines. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
25. EAACI Food Allergy and Anaphylaxis Guidelines. Primary prevention of food allergy.
- Author
-
Muraro, A., Halken, S., Arshad, S. H., Beyer, K., Dubois, A. E. J., Du Toit, G., Eigenmann, P. A., Grimshaw, K. E. C., Hoest, A., Lack, G., O'Mahony, L., Papadopoulos, N. G., Panesar, S., Prescott, S., Roberts, G., Silva, D., Venter, C., Verhasselt, V., Akdis, A. C., and Sheikh, A.
- Subjects
ANAPHYLAXIS ,FOOD allergy prevention ,QUALITY of life ,MEDICAL care costs ,ALLERGY in children ,LACTATION - Abstract
Food allergy can have significant effects on morbidity and quality of life and can be costly in terms of medical visits and treatments. There is therefore considerable interest in generating efficient approaches that may reduce the risk of developing food allergy. This guideline has been prepared by the European Academy of Allergy and Clinical Immunology's ( EAACI) Taskforce on Prevention and is part of the EAACI Guidelines for Food Allergy and Anaphylaxis. It aims to provide evidence-based recommendations for primary prevention of food allergy. A wide range of antenatal, perinatal, neonatal, and childhood strategies were identified and their effectiveness assessed and synthesized in a systematic review. Based on this evidence, families can be provided with evidence-based advice about preventing food allergy, particularly for infants at high risk for development of allergic disease. The advice for all mothers includes a normal diet without restrictions during pregnancy and lactation. For all infants, exclusive breastfeeding is recommended for at least first 4-6 months of life. If breastfeeding is insufficient or not possible, infants at high-risk can be recommended a hypoallergenic formula with a documented preventive effect for the first 4 months. There is no need to avoid introducing complementary foods beyond 4 months, and currently, the evidence does not justify recommendations about either withholding or encouraging exposure to potentially allergenic foods after 4 months once weaning has commenced, irrespective of atopic heredity. There is no evidence to support the use of prebiotics or probiotics for food allergy prevention. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
26. Positive reactions to placebo in children undergoing double-blind, placebo-controlled food challenge.
- Author
-
Ahrens, B., Niggemann, B., Wahn, U., and Beyer, K.
- Subjects
PLACEBOS ,DRUG efficacy ,PEDIATRIC therapy ,FOOD allergy ,BLIND experiment ,SYMPTOMS ,AGE factors in disease - Abstract
Background The gold standard in the diagnosis of food allergy is the double-blind, placebo-controlled oral food challenge ( DBPCFC). During this challenge, patients receive the allergenic food and placebo on separate randomized days, while being monitored for clinical reactions. Interestingly, some reactions are assessed as positive although the patients had received placebo. The aim of our study was to analyze incidence and characteristics of positive placebo reactions during DBPCFCs. Methods In food-allergic children, we retrospectively analyzed positive placebo reactions in DBPCFCs in 740 placebo challenges in our department. Individual characteristics were compared, such as age or IgE levels, as well as clinical symptoms. Results Of all placebo challenges, 2.8% (21 of 740) were assessed as positive. Young children (age ≤ 1.5 years) had more ( P = 0.047) positive placebo challenges (4.0%) compared to older children (age > 1.5 years; 1.5%). Children with positive placebo challenges had higher levels of total IgE (median 201 kU/L) compared to negatively classified children (median 110 kU/L). In children with positive placebo reactions, skin symptoms were observed significantly more often, with a worsening of atopic eczema (AE) as the most reported symptom. Conclusion Placebo reactions in DBPCFC are not common. Worsening of AE is the most frequent clinical reaction associated with positive placebo challenges, and young children (age ≤ 1.5 years) seem to be affected more often. Therefore - contrary to current recommendations - DBPCFC tests should be considered in infants and young children, especially those with a history of AE. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
27. Skin prick test and specific serum IgE in the diagnostic evaluation of suspected cow's milk and hen's egg allergy in children: does one replace the other?
- Author
-
Mehl, A., Niggemann, B., Keil, T., Wahn, U., and Beyer, K.
- Subjects
IMMUNOGLOBULIN E ,IMMUNOGLOBULINS ,FOOD allergy ,ALLERGIES ,ALLERGENS ,ALLERGY in children - Abstract
Background The measurement of specific serum immunoglobulin E ( sIgE) and the skin prick test (SPT) are accepted tools in the diagnostic work-up of suspected food allergy. Often only one of the methods is used to determine sensitization; however, it is still under debate whether these two methods can be used interchangeably. Objectives To investigate the concordance of SPT and sIgE serum assays with regard to suspected food allergy. Methods In 395 children referred to our clinic with suspected cow's milk allergy and in 268 children with suspected hen's egg allergy specific immunoglobulin E (IgE) was measured, a SPT and an oral food challenge performed. A weal size ≥ 3 mm and sIgE ≥ 0.35 kU/L were considered positive. The weal size of the SPT and the level of food-specific IgE were tested for correlation for each allergen. Results Of the 395 (23%) children orally challenged with cow's milk, 92 showed no corresponding results for SPT and sIgE as either positive or negative. For hen's egg, in 27 of 268 (10%) children differing test results for SPT and sIgE in serum were obtained. Moreover, regarding the quantitative values for sIgE and SPT in children with or without clinically relevant food allergy, sIgE and SPT correlated badly. Conclusions The concordance between SPT and sIgE is surprisingly low for cow's milk and hen's egg on an individual basis. Therefore, the tests should not be used interchangeably. Especially in children who receive a negative test result the alternative test should also be used. Furthermore, our data indicate again that oral food challenges are still the method of choice to diagnose food allergies. [ABSTRACT FROM AUTHOR]
- Published
- 2012
- Full Text
- View/download PDF
28. Can we define a tolerable level of risk in food allergy? Report from a Euro Prevall/ UK Food Standards Agency workshop.
- Author
-
Madsen, C. B., Hattersley, S., Allen, K. J., Beyer, K., Chan, C.-H., Godefroy, S. B., Hodgson, R., Mills, E. N. C., Muñoz-Furlong, A., Schnadt, S., Ward, R., Wickman, M., and Crevel, R.
- Subjects
FOOD allergy ,ALLERGIES ,PHYSIOLOGICAL effects of food ,FOOD allergy prevention ,DRUG dosage - Abstract
Summary Background There is an emerging consensus that, as with other risks in society, zero risk for food-allergic people is not a realistic or attainable option. Food allergy challenge data and new risk assessment methods offer the opportunity to develop quantitative limits for unintended allergenic ingredients which can be used in risk-based approaches. However, a prerequisite to their application is defining a tolerable level of risk. This requires a value judgement and is ultimately a 'societal' decision that has to involve all relevant stakeholders. Objective The aim of the workshop was to bring together key representatives from the stakeholders (regulators, food industry, clinical researchers and patients), and for the first time ever discuss the definition of a tolerable level of risk with regard to allergic reactions to food. Results The discussions revealed a consensus that zero risk was not a realistic option and that it is essential to address the current lack of agreed action levels for cross-contamination with allergens if food allergen management practice is to be improved. The discussions also indicated that it was difficult to define and quantify a tolerable level of risk, although both the clinical and the industry groups tried to do so. A consensus emerged that doing nothing was not a viable option, and there was a strong desire to take action to improve the current situation. Conclusions and Clinical Relevance Two concrete actions were suggested: (1) Action levels should be derived from the data currently available. Different scenarios should be examined and further developed in an iterative process. On the basis of this work, a tolerable level of risk should be proposed. (2) 'One-dose' clinical trial with a low challenge dose should be performed in multiple centres to provide additional information about the general applicability of dose-distribution models and help validate the threshold levels derived. [ABSTRACT FROM AUTHOR]
- Published
- 2012
- Full Text
- View/download PDF
29. The role of hen's egg-specific IgE, IgG and IgG4 in the diagnostic procedure of hen's egg allergy Ahrens et al. Hen's egg-specific immunoglobulins in diagnostic approaches.
- Author
-
Ahrens, B., de Oliveira, L. C. Lopes, Schulz, G., Borres, M. P., Niggemann, B., Wahn, U., and Beyer, K.
- Subjects
ALLERGIES ,ALLERGENS ,EGGS ,IMMUNOGLOBULIN G ,IMMUNOGLOBULIN E - Abstract
Background: Hen's egg (HE) allergy is a common disease in childhood. HE-specific serum IgE has been correlated with the outcome of oral food challenge tests, and diagnostic decision points have been described as helpful but still not sufficient to reduce the requirement for oral food challenges. The aim of the study was to correlate HE-specific IgE, IgG and IgG4 levels with the outcome of double-blind, placebo-controlled food challenges (DBPCFC) in patients with suspected HE allergy to improve diagnostic procedures. Methods: HE-specific IgE, IgG, and IgG4 levels were compared between 150 children with suspected HE allergy based on sensitization and/or patient's history who underwent DBPCFC. Sixty-six patients were HE-allergic (HE-sensitized with a positive DBPCFC), 48 HE-sensitized but tolerant (negative DBPCFC), and 36 patients were nonsensitized and tolerant (negative DBPCFC). Prior to food challenge HE-specific serum IgE, IgG, and IgG4 were measured with the Phadia CAP-system. Results: HE-specific IgE was significantly higher in HE-allergic patients than in clinically tolerant ones. However, there was no difference in HE-specific IgG and IgG4 concentrations between the patient groups. Conclusion: A proposed cut-off level of 12 kU/l IgE would identify children above this level correctly as HE-allergic. The level of HE-specific IgG or IgG4 in serum of children with suspected HE allergy does not add any additional information in the diagnostic procedure of HE allergy. For diagnostic purposes, specific IgG or IgG4 should not routinely be tested. [ABSTRACT FROM AUTHOR]
- Published
- 2010
- Full Text
- View/download PDF
30. The management of the allergic child at school: EAACI/GA2LEN Task Force on the allergic child at school.
- Author
-
Muraro, A., Clark, A., Beyer, K., Borrego, L. M., Borres, M., Carlsen, K. C. Lødrup, Carrer, P., Mazon, A., Ranc, F., Valovirta, E., Wickman, M., and Zanchetti, M.
- Subjects
ALLERGY in children ,SCHOOL children ,ASTHMA in children ,RHINITIS ,ECZEMA ,FOOD allergy - Abstract
To cite this article: Muraro A, Clark A, Beyer K, Borrego LM, Borres M, Lødrup Carlsen KC, Carrer P, Mazon A, Rancè F, Valovirta E, Wickman M, Zanchetti M. The management of the allergic child at school: EAACI/GA
2 LEN Task Force on the allergic child at school. Allergy 2010; 65: 681–689. Allergy affects at least one-quarter of European schoolchildren, it reduces quality of life and may impair school performance; there is a risk of severe reactions and, in rare cases, death. Allergy is a multi-system disorder, and children often have several co-existing diseases, i.e. allergic rhinitis, asthma, eczema and food allergy. Severe food allergy reactions may occur for the first time at school, and overall 20% of food allergy reactions occur in schools. Up to two-thirds of schools have at least one child at risk of anaphylaxis but many are poorly prepared. A cooperative partnership between doctors, community and school nurses, school staff, parents and the child is necessary to ensure allergic children are protected. Schools and doctors should adopt a comprehensive approach to allergy training, ensuring that all staff can prevent, recognize and initiate treatment of allergic reactions. [ABSTRACT FROM AUTHOR]- Published
- 2010
- Full Text
- View/download PDF
31. Infant feeding and allergy prevention: a review of current knowledge and recommendations. A EuroPrevall state of the art paper.
- Author
-
Grimshaw, K. E. C., Allen, K., Edwards, C. A., Beyer, K., Boulay, A., van der Aa, L. B., Sprikkelman, A., Belohlavkova, S., Clausen, M., Dubakiene, R., Duggan, E., Reche, M., Marino, L. V., Nørhede, P., Ogorodova, L., Schoemaker, A., Stanczyk-Przyluska, A., Szepfalusi, Z., Vassilopoulou, E., and Veehof, S. H. E.
- Subjects
INFANTS ,FOOD allergy in children ,IMMUNOLOGY ,ALLERGIES - Abstract
The relationship between infant feeding patterns and the later development of food allergies has been the focus of much debate and research over the last decade. National recommendations have been made by many countries on how to feed infants to reduce the risk of food allergy but due to the lack of firm evidence the recommendations differ widely. This review has been developed as part of EuroPrevall, a European multicentre research project funded by the European Union, to document the differing feeding recommendations made across Europe, to investigate the current evidence base for any allergy prevention feeding recommendations and to identify areas where further research is needed. This review will also provide information which, when combined with the infant feeding data collected as part of EuroPrevall, will give an indication of compliance to national feeding guidelines which can be utilised to assess the effectiveness of current dissemination and implementation strategies. [ABSTRACT FROM AUTHOR]
- Published
- 2009
- Full Text
- View/download PDF
32. Factors influencing the incidence and prevalence of food allergy.
- Author
-
Cochrane, S., Beyer, K., Clausen, M., Wjst, M., Hiller, R., Nicoletti, C., Szepfalusi, Z., Savelkoul, H., Breiteneder, H., Manios, Y., Crittenden, R., and Burney, P.
- Subjects
- *
FOOD allergy , *GENETIC polymorphisms , *ALLERGENS , *PUBLIC health , *DISEASE risk factors - Abstract
Food allergy is an increasing problem in Europe and elsewhere and severe reactions to food are also becoming more common. As food allergy is usually associated with other forms of allergic sensitisation it is likely that many risk factors are common to all forms of allergy. However the potential severity of the disease and the specific public heath measures required for food allergy make it important to identify the specific risk factors for this condition. Food allergy is unusual in that it often manifests itself very early in life and commonly remits with the development of tolerance. Hypotheses that explain the distribution of food allergy include specific genetic polymorphisms, the nature of the allergens involved and the unique exposure to large quantities of allergen through the gut. Progress has been made in developing more specific and testable hypotheses but the evidence for any of these is still only preliminary. Further collaborative research is required to develop an appropriate public health response to this growing problem. [ABSTRACT FROM AUTHOR]
- Published
- 2009
- Full Text
- View/download PDF
33. Clinical usefulness of microarray-based IgE detection in children with suspected food allergy.
- Author
-
Ott, H., Baron, J. M., Heise, R., Ocklenburg, C., Stanzel, S., Merk, H.-F., Niggemann, B., and Beyer, K.
- Subjects
FOOD allergy ,ALLERGENS ,ALLERGIES ,IMMUNOLOGIC diseases ,BLOOD ,IMMUNOGLOBULIN E - Abstract
Background: Component-resolved diagnostics using microarray technology has recently been introduced into clinical allergology, but its applicability in children with food allergy has hardly been investigated so far. The aim of this study was to evaluate the utility of microarray-based IgE detection in the diagnostic workup of food allergy and to compare this new diagnostic tool with established methods of allergen-specific IgE detection. Methods: We investigated 130 infants and children with suspected allergy to cow’s milk (CM) or hen’s egg (HE). Serum IgE measurements, skin prick tests, allergen microarray assays and controlled oral food challenges with HE and CM were performed. Results: We analyzed 145 oral challenges that served as reference parameters for assay performance assessment. On this basis, the panel of microarrayed allergen components was shown to represent a comprehensive repertoire of clinically relevant CM and HE proteins. Additionally, the implemented CM and HE components respectively sufficed for equivalent test performance as compared to the corresponding fluorescence enzyme immunoassay extract and skin testing. However, component-resolved diagnostics for HE and CM allergy did not make oral food challenges superfluous. Clinical IgE decision points predicting positive oral food challenges could be calculated for both in vitro test methods. Conclusions: Allergen microarrays provide a new tool to diagnose symptomatic CM and HE allergy. They show performance characteristics comparable to the current diagnostic tests and may be indicated in small children in whom only small blood volumes are obtainable. However, they are not capable of replacing double-blind, placebo-controlled food challenges in most cases. [ABSTRACT FROM AUTHOR]
- Published
- 2008
- Full Text
- View/download PDF
34. Primary versus secondary immunoglobulin E sensitization to soy and wheat in the Multi-Centre Allergy Study cohort.
- Author
-
Matricardi, P. M., Bockelbrink, A., Beyer, K., Keil, T., Niggemann, B., Grüber, C., Wahn, U., and Lau, S.
- Subjects
TRANSFER factor (Immunology) ,IMMUNOGLOBULIN E ,FOOD allergy ,ALLERGENS ,COHORT analysis - Abstract
Background IgE sensitization to soy and wheat is classified as ‘primary’ when generated by food ingestion and ‘secondary’ when it as a consequence of primary sensitization to cross-reacting pollen antigens via inhalation. The age-specific relevance of these categories of sensitization throughout childhood is unknown. Objective To monitor the natural course of IgE sensitization against common food allergens in childhood in relation to sensitization against cross-reactive airborne allergens. Methods The German Multi-Centre Allergy Study with follow-up from birth to age 13 recruited initially 1314 children. IgE antibody levels against cow's milk, hen's egg, soy, wheat, mites, cat and dog dander, birch and grass pollens were tested. Longitudinal data were analysed from the 273 children with sera obtained at age 2, 5, 7 and 10 years of age. Results The point prevalence of sensitization (>1.0 kU/L) to milk and egg allergens progressively decreased from about 4% at 2 years to <1% at 10 years. By contrast, the prevalence of IgE to wheat and soy progressively increased with age, from 2% to 7% (soy) and from 2% to 9% (wheat). At 10 years of age, IgE to grass pollen was detected in 97% and 98% of the children reacting against soy and wheat, respectively; IgE to birch pollen was observed in 86% and 82% of the children reacting against soy and wheat, respectively. Early IgE sensitization to soy or wheat preceded that to grass or birch pollen in only 4% and 8% of participants sensitized to soy and wheat, respectively. Conclusion IgE sensitization to soy and wheat is relatively uncommon and mostly primary in early infancy, more frequent and mostly secondary to pollen sensitization at school age. Clinical Implications Awareness should be raised to avoid unnecessary diet restrictions due to the high frequency of clinically irrelevant, secondary sensitization to soy and wheat in schoolchildren with pollinosis. [ABSTRACT FROM AUTHOR]
- Published
- 2008
- Full Text
- View/download PDF
35. Specific oral tolerance induction in food allergy in children: efficacy and clinical patterns of reaction.
- Author
-
Staden, U., Rolinck-Werninghaus, C., Brewe, F., Wahn, U., Niggemann, B., and Beyer, K.
- Subjects
SKIN diseases ,IMMUNOGLOBULIN E ,FOOD allergy in children ,ALLERGY in children ,FOOD allergy ,ALLERGENS - Abstract
Background: Specific oral tolerance induction (SOTI) seems to be a promising treatment of food allergy. Specific oral tolerance induction and elimination diet were compared with respect to efficacy rate and patterns of clinical reaction. Methods: Children with challenge proven immunoglobulin E (IgE)-mediated cow’s milk (CM) allergy or hen’s egg (HE) allergy were randomly assigned to SOTI or elimination diet as a control group. Specific oral tolerance induction treatment was performed at home on a daily basis according to a study protocol with fresh CM or lyophilized HE protein. Re-evaluation of clinically relevant food allergy was performed by food challenge after a median of 21 months. Children in the SOTI group received a secondary elimination diet for 2 months prior to follow-up challenge to evaluate persistence of induced oral tolerance. Results: At follow-up challenge, nine of 25 children (36%) showed permanent tolerance in the SOTI group, three of 25 (12%) were tolerant with regular intake and four of 25 (16%) were partial responders. In the control group, seven of 20 children (35%) were tolerant. Allergen-specific immunoglobulin E decreased significantly both in children who developed natural tolerance during the elimination diet ( P < 0.05) and in those with SOTI ( P < 0.001). Conclusions: Specific oral tolerance induction seems a valid treatment option for patients with persistent food allergy. Indications may be given if avoidance cannot be guaranteed or for those who are eager to eat the food in question. Advantages of SOTI are the increased threshold dose for allergic reactions and the substantially reduced risk of severe allergic reactions after inadvertent ingestion of the allergen. However, careful monitoring during SOTI is mandatory. [ABSTRACT FROM AUTHOR]
- Published
- 2007
- Full Text
- View/download PDF
36. Pitfalls in double-blind, placebo-controlled oral food challenges.
- Author
-
Niggemann, B. and Beyer, K.
- Subjects
- *
ALLERGIES , *FOOD allergy , *PLACEBOS , *ATOPIC dermatitis , *DIET therapy for food allergies , *SKIN inflammation , *IMMUNOLOGIC diseases , *ALLERGY treatment , *ECZEMA - Abstract
Although controlled oral food challenges are considered to be the gold-standard in the diagnosis of food related symptoms, especially if performed in a double-blind, placebo-controlled food challenges (DBPCFC) manner, there are still many unanswered questions and newer aspects, which may explain some pitfalls encountered during oral food challenges. For stopping an oral food challenge and declaring a challenge as positive or negative, symptoms should be objective and/or repetitive. The time interval between administering the food and observing the clinical reaction is an ambivalent factor. Possible reasons for false negative assessments include inadvertent drug use during oral challenges, and the fact that a short-term specific oral tolerance induction (SOTI) may be induced as increasing amounts of the offended food are administered during a titrated oral food challenge. Possible reasons for false positive assessments are the difficulty to maintain an appropriate strict diet throughout the oral challenge procedure, and that the elimination diet implemented before the oral food challenge in children with atopic eczema and suspected food related symptoms may itself be responsible for immediate type clinical symptoms, which had not been reported by the parents before. Finally augmentation factors are among the most plausible explanations for the inadequate reproducibility of an oral food challenge. Although a 100% standardization of the challenge procedure does not seem realistic, efforts should be made to improve the methodology used so far. On the contrary, the possible relation of DBPCFC and SOTI may offer potential advantages for future therapeutic approaches of food allergy. [ABSTRACT FROM AUTHOR]
- Published
- 2007
- Full Text
- View/download PDF
37. The prevalence, cost and basis of food allergy across Europe.
- Author
-
Mills, E. N. C., Mackie, A. R., Burney, P., Beyer, K., Frewer, L., Madsen, C., Botjes, E., Crevel, R. W. R., and van Ree, R.
- Subjects
ALLERGIES ,FOOD allergy ,SOCIAL factors ,SOCIOECONOMICS ,SERUM ,BLOOD banks ,BLOOD plasma ,IMMUNOLOGIC diseases - Abstract
The development of effective management strategies to optimize the quality of life for allergic patients is currently hampered by a lack of good quality information. Estimates of how many individuals suffer from food allergy and the major foods involved vary widely and inadequacies of in vitro diagnostics make food challenges the only reliable means of diagnosis in many instances. The EuroPrevall project brings together a multidisciplinary partnership to address these issues. Cohorts spanning the main climatic regions of Europe are being developed in infants through a birth cohort, community surveys in school-age children and adults and an outpatient clinic study. Confirmatory double-blind placebo-controlled food challenge diagnosis is being undertaken using foods as they are eaten with titrated doses to allow no-effect and lowest-observable effect levels for allergenic foods to be determined. The cohorts will also facilitate validation of novel in vitro diagnostics through the development of the EuroPrevall Serum Bank. Complementary studies in Ghana, western Siberia, India and China will allow us to gain insights into how different dietary patterns and exposure to microorganisms affect food allergies. New instruments to assess the socioeconomic impact of food allergy are being developed in the project and their application in the clinical cohorts will allow, for the first time, an assessment to be made of the burden this disease places on allergy sufferers and their communities. [ABSTRACT FROM AUTHOR]
- Published
- 2007
- Full Text
- View/download PDF
38. The predictive value of the skin prick test weal size for the outcome of oral food challenges.
- Author
-
Verstege, A., Mehl, A., Rolinck-Werninghaus, C., Staden, U., Nocon, M., Beyer, K., and Niggemann, B.
- Subjects
FOOD allergy ,IMMUNOLOGIC diseases ,MILK ,SKIN tests ,CLINICAL trials ,PLACEBOS - Abstract
Background The skin prick test (SPT) is regarded as an important diagnostic measure in the diagnostic work-up of food allergy. Objective To evaluate the diagnostic capacity of the SPT in predicting the outcome of oral food challenges, and to determine decision points for the weal size and the skin index (SI) that could render double-blind, placebo-controlled food challenges unnecessary. Methods In 385 children (median age 22 months), 735 controlled oral challenges were performed with cow's milk (CM), hen's egg (HE), wheat and soy. Three hundred and thirty-six of 385 (87%) children suffered from atopic dermatitis. SPT was performed in all children. Diagnostic capacity, receiver–operator characteristics (ROC) curves and predictive decision points were calculated for the mean weal size and the calculated SI. Results Three hundred and twelve of 735 (43%) oral food challenges were assessed to be positive. Calculation of 95% and 99% predicted probabilities using logistic regression revealed predictive decision points of 13.0 and 17.8 mm for HE, and 12.5 and 17.3 mm for CM, respectively. However, using the SI, the corresponding cut-off levels were 2.6 and 3.7, respectively, for HE, and 2.7 and 3.7 for CM. For wheat, 95% and 99% decision points of 2.2 and 3.0 were found in children below 1 year of age. Conclusion Predictive decision points for a positive outcome of food challenges can be calculated for HE and CM using weal size and SI. They may help to avoid oral food challenges. [ABSTRACT FROM AUTHOR]
- Published
- 2005
- Full Text
- View/download PDF
39. Utility of the ratio of food-speci?c IgE/total IgE in predicting symptomatic food allergy in children.
- Author
-
Mehl, A., Verstege, A., Staden, U., Kulig, M., Nocon, M., Beyer, K., and Niggemann, B.
- Subjects
FOOD allergy ,IMMUNOGLOBULIN E ,FOOD allergy in children ,IMMUNOLOGIC diseases ,WHEAT ,SOYFOODS - Abstract
Double-blind, placebo-controlled food challenges are time-consuming, expensive and not without risk to patients. Therefore, an in vitro test that could accurately diagnose food allergy would be of great value. To evaluate the utility of the ratio of specific immunoglobulin E (IgE)/total IgE compared with specific IgE (sIgE) alone in predicting symptomatic food allergy. We retrospectively analysed 992 controlled oral food challenges performed in 501 children (median age 13 months). The ratio of sIgE/total IgE was calculated and tested for correlation with the outcome of food challenges. Receiver operator characteristics (ROC)-curves were performed; predicted probabilities and predictive decision points were calculated. A significant correlation was found between the ratio and the outcome of food challenges for cow's milk (CM), hen's egg (HE), and wheat, but not for soy. The ROC and predicted probability curves as well as sensitivity and specificity of the decision points of the ratio were similar to those of sIgE levels for CM, HE and wheat. In view of the greater effort needed to determine the ratio, without benefit compared with the sIgE alone, the calculation of the ratio of sIgE/total IgE for diagnosing symptomatic food allergy offers no advantage for CM, HE, wheat or soy. For the majority of cases controlled oral food challenges still remain the method of choice. [ABSTRACT FROM AUTHOR]
- Published
- 2005
- Full Text
- View/download PDF
40. The predictive value of specific immunoglobulin E levels in serum for the outcome of oral food challenges.
- Author
-
Celik-Bilgili, S., Mehl, A., Verstege, A., Staden, U., Nocon, M., Beyer, K., and Niggemann, B.
- Subjects
IMMUNOGLOBULIN E ,ALLERGIES ,ATOPIC dermatitis ,IMMUNOGLOBULINS ,BLOOD plasma ,SKIN inflammation ,PLACEBOS - Abstract
Specific serum IgE is considered as one of the important diagnostic measures in the diagnostic work-up of food allergy.To evaluate the role of specific serum IgE in predicting the outcome of oral food challenges, and to determine threshold concentrations of specific serum IgE that could render double-blind, placebo-controlled food challenges unnecessary.In 501 children (median age 13 months), 992 controlled oral challenges were performed with cow's milk (CM), hen's egg (HE), wheat and soy. 440/501 (88%) children suffered from atopic dermatitis. For all children, specific IgE concentrations in serum were determined. Sensitivity, specificity, positive and negative predictive values, receiver operator characteristics-curves as well as predictive decision points were calculated.Four hundred and forty-five out of 992 oral food challenges with allergens were assessed as positive. Sensitivity of specific serum IgE was 97% for HE, 83% for CM, 69% for soy, and 79% for wheat. Specificity was 51% for HE, 53% for CM, 50% for soy, and 38% for wheat. Calculating 90%, 95% and 99% predicted probabilities using logistic regression revealed predictive decision points of 6.3, 12.6, and 59.2 kU/L for HE, respectively. Subdividing our children in those of below or above 1 year of age resulted in a markedly different predicted probability for HE. For CM, only the 90% predicted probability (88.8 kU/L) could be calculated. No decision points could be determined for CM, wheat and soy.In general, specific serum IgE levels showed a correlation with the outcome of positive oral food challenges for CM and HE. Meaningful predictive decision points can be calculated for HE, which may help to avoid oral food challenges in some cases. However, data need to be ascertained for each allergen separately. Furthermore, the age of the patient population under investigation must also be taken into account. [ABSTRACT FROM AUTHOR]
- Published
- 2005
- Full Text
- View/download PDF
41. Diagnostic pitfalls in food allergy in children.
- Author
-
Niggemann, B. and Beyer, K.
- Subjects
- *
FOOD allergy in children , *DIFFERENTIAL diagnosis , *SKIN tests , *MEDICAL screening , *SYMPTOMS , *ALLERGY in children , *IMMUNOLOGIC diseases - Abstract
Currently, the diagnostic work-up of suspected food allergy includes skin prick tests, the measurement of food specific immunoglobulin E (IgE), and the atopy patch test, and double-blind, placebo-controlled food challenges. However, all of these methods, even double-blind, placebo-controlled food challenges (DBPCFC), may sometimes be misleading. This overview describes several pitfalls for standard diagnostic methods such as problems with irritative skin reactions mimicking IgE-mediated symptoms, the problem of non-IgE-mediated reactions, pitfalls arising from the way foods are prepared or processed, effects of the route of exposure, the role of augmentation factors lowering the threshold value for clinical reactions, the noncomparability of specific IgE decision points, the influence of the timing of diagnostic measures. In addition, the problem of alternative diagnostic measures is discussed. In conclusion, there are several pitfalls in the diagnostic work-up of food allergy, which may be misleading for the physician. Properly performed controlled oral food challenges still represent the gold standard for implementing specific diets in food allergic individuals in order to avoid both unjustified diets, which may lead to severe impairments in growth and development, and to avoid unnecessary symptoms if an underlying food allergy is not correctly identified as a cause for the symptoms of the patient. [ABSTRACT FROM AUTHOR]
- Published
- 2005
- Full Text
- View/download PDF
42. Identification of IgE and IgG binding epitopes on β- and κ-casein in cow's milk allergic patients.
- Author
-
Chatchatee, P., Järvinen, K.-M., Bardina, L., Vila, L., Beyer, K., and Sampson, H. A.
- Subjects
MILK ,FOOD allergy - Abstract
BackgroundCow's milk allergy (CMA) affects 2.5% of children aged less than 2 years of age. Although β- and κ-casein are considered among the major allergens responsible for CMA, no data are available on their allergenic epitopes in humans. ObjectiveThe aim of the study was to identify IgE- and IgG-binding epitopes on β- and κ-casein and to determine whether the pattern of epitope recognition is associated with the natural history of CMA. MethodsOverlapping decapeptides representing the entire length of β- and κ-casein, respectively, were synthesized on a cellulose-derivatized membrane. Sera from 15 milk-allergic children, 4–18 years of age, with high levels of specific IgE antibodies to cow's milk were used to identify IgE- and IgG-binding epitopes. In addition, IgE epitopes were screened with pooled or individual sera from younger patients aged less than 3 years and who had low levels of specific serum IgE, who are likely to outgrow CMA. ResultsSix major and three minor IgE-binding epitopes, as well as eight major and one minor IgG binding regions, were identified on β-casein. Eight major IgE-binding epitopes, as well as two major and two minor IgG-binding epitopes, were detected on κ-casein. Three of the IgE binding regions on β-casein and six on κ-casein were recognized by the majority of patients in the older age group, but not by the younger patients. ConclusionInformation regarding the immunodominant epitopes in β- and κ-casein may be important for understanding the pathophysiology and natural history of CMA. Differences in epitope recognition may be useful in identifying children who will have persistent milk hypersensitivity. [ABSTRACT FROM AUTHOR]
- Published
- 2001
- Full Text
- View/download PDF
43. Vitamin D in early life: good or bad for food allergies?
- Author
-
Querfeld, U., Keil, T., Beyer, K., Stock, P., Pilz, S., März, W., Weisse, K., and Lehmann, I.
- Subjects
VITAMIN D deficiency ,ALLERGY in children ,SERUM ,IMMUNOGLOBULIN E ,FOOD allergy ,LOW birth weight ,T cells - Abstract
The article focuses on the impacts of 25-Hydroxyvitamin D3 (25-OHD) levels and nutritional vitamin D supplementation on the development of allergic diseases during childhood. It states that the 25-OH-D3 level is associated with the serum level of IgE (immunoglobulin E) of child which is specific for food allergens. It mentions that vitamin D deficiency is also associated with low birth weight and is correlated with regulatory T-cells.
- Published
- 2013
- Full Text
- View/download PDF
44. Specific oral tolerance induction with food in children: transient or persistent effect on food allergy?
- Author
-
Rolinck-Werninghaus, C., Staden, U., Mehl, A., Hamelmann, E., Beyer, K., and Niggemann, B.
- Subjects
FOOD allergy ,ALLERGIES ,IMMUNOLOGIC diseases ,BIOCHEMISTRY - Abstract
Background: The standard treatment of food allergy is elimination of the incriminated food from the diet. Specific oral tolerance induction (SOTI) seems to be a promising approach for a causal treatment; however, it is unclear whether the tolerance achieved is transient or persistent. We report on a subset of three patients of a larger ongoing study who were treated successfully with SOTI treatment, but experienced a secondary loss of tolerance after a period of allergen avoidance. Methods: The patients suffered from IgE-mediated allergy either to cow's milk (CM) (patient A) or hen's egg (HE) (patients B and C), confirmed by double-blind, placebo-controlled food challenge (DBPCFC). SOTI treatment was performed at home on a daily basis until tolerance to a maximum of 250 ml CM or 4.5 g lyophilized HE protein was achieved. The daily maintenance dose was 100 ml CM or 2.5 g HE protein. Results: Patients A, B and C reached tolerance to the maximum dose after 37, 41 and 52 weeks, respectively. According to the protocol, patients A and B performed a strict secondary elimination diet for 2 months prior to a follow-up DBPCFC after a maintenance phase of 27 and 39 weeks, respectively. Patient C discontinued treatment for 2 days after 4 weeks on the maintenance dose. Despite previous tolerance, on re-exposure to the allergen all patients experienced moderate systemic allergic reactions. Conclusions: We conclude that SOTI can induce transient tolerance in food allergy, but does not necessarily lead to its permanent abrogation. Regular allergen intake seems necessary to maintain the established tolerance. [ABSTRACT FROM AUTHOR]
- Published
- 2005
- Full Text
- View/download PDF
45. Effect of freezing foods for the outcome of skin prick tests.
- Author
-
Ziegert, M., Beyer, K., Wahn, U., and Niggemann, B.
- Subjects
- *
ALLERGIES , *ALLERGENS , *FOOD allergy , *CRYOBIOLOGY , *FROZEN foods - Abstract
The article presents a research on the effect of freezing foods for the skin prick tests outcome. A study is made on freezing fresh foods such as cow's milk and eggs prior to performing skin prick tests is undertaken to compare its reliability as compared against fresh foods. It is found out that freezing foods does not alter their allergenic characters.
- Published
- 2007
- Full Text
- View/download PDF
46. Circulating soluble L‐selectin in atopic dermatitis.
- Author
-
Bührer, C., Beyer, K., and Niggemann, B.
- Subjects
- *
GLYCOPROTEINS , *ATOPIC dermatitis , *PHYSIOLOGY - Abstract
Examines the circulation of transmembrane glycoprotein L-selectin in atopic dermatitis. Clinical manifestations of allergic diseases; Role of the leukocyte surface transmembrane glycoprotein L-selectin in white blood cell transport; Frequency of effector leukocytes involved in an allergic reaction.
- Published
- 1999
- Full Text
- View/download PDF
47. Performance of a polymer coated silicon microarray for simultaneous detection of food allergen-specific IgE and IgG4.
- Author
-
Sievers, S., Cretich, M., Gagni, P., Ahrens, B., Grishina, G., Sampson, H. A., Niggemann, B., Chiari, M., and Beyer, K.
- Subjects
- *
FOOD allergy , *ALLERGENS , *FOOD substitutes , *GASTRONOMY , *BASIC needs - Abstract
Background Microarray-based component-resolved diagnostics (CRD) has become an accepted tool to detect allergen-specific IgE sensitization towards hundreds of allergens in parallel from one drop of serum. Nevertheless, specificity and sensitivity as well as a simultaneous detection of allergen-specific IgG4, as a potential parameter for tolerance development, remain to be optimized. Objective We applied the recently introduced silicon chip coated with a functional polymer named copoly(DMA-NAS-MAPS) to the simultaneous detection of food allergen-specific IgE and IgG4, and compared it with ImmunoCAP and ImmunoCAP ISAC. Inter- and intraslide variation, linearity of signal and working range, sensitivity and application of internal calibrations for IgE and IgG4 were assessed. Methods Native and recombinant allergenic proteins from hen's egg and cow's milk were spotted on silicon chips coated with copoly(DMA-NAS-MAPS) along with known concentrations for human IgE and IgG4. A serum pool and 105 patient samples were assessed quantitatively and semi-quantitatively with the ImmunoCAP and ImmunoCAP ISAC and correlated with IgE- and IgG4-specific fluorescence on silicon microarrays. Results Allergen-specific IgE and IgG4 were detected in parallel using two fluorescent dyes with no crosstalk. Results from the ImmunoCAP correlated better with microarray fluorescence than with ImmunoCAP ISAC except for the allergen ovomucoid. The working range of the silicon microarray for total hen's egg-specific IgE was comparable to the range of 0.1 to >100 kUA/L of the ImmunoCAP system, whereas for total cow's milk, the silicon microarray was less sensitive. Detectable allergen-specific IgG4 could be determined only for low concentrations, but still correlated positively with ImmunoCAP results. Conclusions We confirmed the ability of the polymer coated silicon microarray to be comparably sensitive to the ImmunoCAP ISAC for various food allergens. This suggests that the copoly(DMA-NAS-MAPS) microarray is a low-cost, self-producible alternative to the commercial ImmunoCAP ISAC in allergy research. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
48. Allergen immunotherapy for IgE-mediated food allergy:protocol for a systematic review
- Author
-
Lars K. Poulsen, Graham Roberts, Montserrat Fernandez-Rivas, Hugh A. Sampson, Frans Timmermans, Philippe Eigenmann, Nikolaos G. Papadopoulos, Edward F. Knol, Montserrat Alvaro-Lozano, Mika J. Mäkelä, Motohiro Ebisawa, George Du Toit, Kari C. Nadeau, Wesley Burks, Ulugbek Nurmatov, Cansin Sackesen, Cezmi A. Akdis, Giovanni Battista Pajno, Kirsten Beyer, Ronald van Ree, Alexandra F. Santos, Aziz Sheikh, Antonella Muraro, Carsten Bindslev-Jensen, Sangeeta Dhami, Liam O'Mahony, AII - Inflammatory diseases, Experimental Immunology, APH - Amsterdam Public Health, AII - Amsterdam institute for Infection and Immunity, Saçkesen, Cansın (ORCID 0000-0002-1115-9805 & YÖK ID 182537), Dhami, S., Nurmatov, U., Pajno, G. B., Fernandez-Rivas, M., Muraro, A., Roberts, G., Akdiş, C., Alvaro-Lozano, M., Beyer, K., Bindslev-Jensen, C., Burks, W., du Toit, G., Ebisawa, M., Eigenmann, P., Knol, E., Makela, M., Nadeau, K. C., O'Mahony, L., Papadopoulos, N., Poulsen, L., Sampson, H., Santos, A., van Ree, R., Timmermans, F., Sheikh, A., School of Medicine, Department of Pediatrics, Clinicum, and Department of Dermatology, Allergology and Venereology
- Subjects
Pulmonary and Respiratory Medicine ,Allergen immunotherapy ,medicine.medical_specialty ,Allergy ,EUROPE ,Clinical immunology ,Immunology ,Peanut allergy ,Alternative medicine ,Study Protocol ,03 medical and health sciences ,0302 clinical medicine ,Ige mediated ,QUALITY-OF-LIFE ,Food allergy ,Journal Article ,Immunology and Allergy ,Medicine ,Intensive care medicine ,METAANALYSIS ,Sensitisation ,Therapy ,Protocol (science) ,ddc:618 ,business.industry ,Quality-Of-Life ,Peanut Allergy ,Metaanalysis ,Europe ,Bias ,PEANUT ALLERGY ,medicine.disease ,R1 ,3. Good health ,BIAS ,030228 respiratory system ,3121 General medicine, internal medicine and other clinical medicine ,Erratum ,business ,Pediatrics ,030215 immunology - Abstract
Background: The European Academy of Allergy and Clinical Immunology (EAACI) is in the process of developing the EAACI Guidelines for Allergen Immunotherapy (AIT) for IgE-mediated food allergy. We seek to critically assess the effectiveness, cost-effectiveness and safety of AIT in IgE-mediated food allergy. Methods: We will undertake a systematic review, which will involve searching international biomedical databases for published, in progress and unpublished evidence. Studies will be independently screened against pre-defined eligibility criteria and critically appraised using established instruments. Data will be descriptively and, if possible and appropriate, quantitatively synthesised. Discussion: The findings from this review will be used to inform the development of recommendations for EAACI's Guidelines on AIT., EAACI
- Published
- 2016
49. Diagnosis and Rationale for Action Against Cow's Milk Allergy (DRACMA): a summary report
- Author
-
Arabella Martelli, Amal Assa'ad, Carlos E. Baena-Cagnani, Sami L. Bahna, F. Rancé, Kirsten Beyer, Walter Canonica, Patrizia Restani, Gabriel R. Bouygue, Motohiro Ebisawa, Richard F. Lockey, Ralf G. Heine, Jan Brozek, Alessandro Fiocchi, Riccardo Troncone, Holger J. Schünemann, Elvira Verduci, Luigi Terracciano, Hugh A. Sampson, Fiocchi, A, Schunemann, Hj, Brozek, J, Restani, P, Beyer, K, Troncone, Riccardo, Martelli, A, Terracciano, L, Bahna, Sl, Rance', F, Ebisawa, M, Heine, Rg, Assa'Ad, A, Sampson, H, Verduci, E, Bouygue, Gr, BAENA CAGNANI, C, Canonica, W, and Lockley, R. F.
- Subjects
Research Report ,medicine.medical_specialty ,Pediatrics ,Consensus Development Conferences as Topic ,Immunology ,Alternative medicine ,MEDLINE ,Milk allergy ,Translational Research, Biomedical ,Food allergy ,Epidemiology ,medicine ,Immunology and Allergy ,Animals ,Humans ,Pathology, Molecular ,Grading (education) ,Oral food challenge ,business.industry ,medicine.disease ,Microarray Analysis ,Natural history ,Family medicine ,Practice Guidelines as Topic ,Cattle ,Immunotherapy ,Milk Hypersensitivity ,business - Abstract
The 2nd Milan Meeting on Adverse Reactions to Bovine Proteins was the venue for the presentation of the first consensus-based approach to the management of cow's milk allergy. It was also the first time that the Grading of Recommendations, Assessments, Development, and Evaluation approach for formulating guidelines and recommendations was applied to the field of food allergy. In this report we present the contributions in allergen science, epidemiology, natural history, evidence-based diagnosis, and therapy synthesized in the World Allergy Organization Diagnosis and Rationale for Action against Cow's Milk Allergy guidelines and presented during the meeting. A consensus emerged between discussants that cow's milk allergy management should reflect not only basic research but also a newer and better appraisal of the literature in the light of the values and preferences shared by patients and their caregivers in partnership. In the field of diagnosis, atopy patch testing and microarray technology have not yet evolved for use outside the research setting. With foreseeable breakthroughs (eg, immunotherapy and molecular diagnosis) in the offing, the step ahead in leadership can only stem from a worldwide organization implementing consensus-based clinical practice guidelines to diffuse and share clinical knowledge.
- Published
- 2010
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.